28.63
price down icon0.62%   -0.18
after-market Handel nachbörslich: 28.58 -0.05 -0.17%
loading
Schlusskurs vom Vortag:
$28.81
Offen:
$28.81
24-Stunden-Volumen:
159.59K
Relative Volume:
0.77
Marktkapitalisierung:
$409.34M
Einnahmen:
$138.20M
Nettoeinkommen (Verlust:
$5.52M
KGV:
75.34
EPS:
0.38
Netto-Cashflow:
$9.86M
1W Leistung:
-1.68%
1M Leistung:
-10.87%
6M Leistung:
+5.10%
1J Leistung:
-25.94%
1-Tages-Spanne:
Value
$28.49
$28.81
1-Wochen-Bereich:
Value
$28.49
$29.16
52-Wochen-Spanne:
Value
$26.00
$40.38

Surmodics Inc Stock (SRDX) Company Profile

Name
Firmenname
Surmodics Inc
Name
Telefon
(952) 500-7000
Name
Adresse
9924 W 74TH ST, EDEN PRAIRIE, MN
Name
Mitarbeiter
389
Name
Twitter
Name
Nächster Verdiensttermin
2025-08-08
Name
Neueste SEC-Einreichungen
Name
SRDX's Discussions on Twitter

Vergleichen Sie SRDX mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Medical Devices icon
SRDX
Surmodics Inc
28.63 411.91M 138.20M 5.52M 9.86M 0.38
Medical Devices icon
ABT
Abbott Laboratories
132.57 232.02B 43.11B 13.94B 6.78B 7.9963
Medical Devices icon
BSX
Boston Scientific Corp
95.41 144.14B 18.49B 2.50B 3.49B 1.6801
Medical Devices icon
SYK
Stryker Corp
364.60 141.53B 23.82B 2.92B 4.02B 7.5574
Medical Devices icon
MDT
Medtronic Plc
95.45 123.78B 34.20B 4.69B 5.30B 3.6218
Medical Devices icon
EW
Edwards Lifesciences Corp
73.94 44.14B 5.69B 1.41B 577.90M 6.9828

Surmodics Inc Stock (SRDX) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-03-07 Hochstufung Lake Street Hold → Buy
2023-06-13 Hochstufung Needham Hold → Buy
2023-02-13 Herabstufung Needham Buy → Hold
2020-07-23 Hochstufung Needham Hold → Buy
2019-12-11 Herabstufung Needham Buy → Hold
2019-11-01 Herabstufung Lake Street Buy → Hold
2019-08-01 Bestätigt Needham Buy
2019-05-02 Bestätigt Lake Street Buy
2019-05-02 Bestätigt Needham Buy
2019-02-21 Bestätigt Needham Buy
2018-05-16 Bestätigt Needham Buy
2018-03-01 Hochstufung Sidoti Neutral → Buy
2018-02-28 Bestätigt Lake Street Buy
2018-02-28 Eingeleitet Needham Buy
2017-07-14 Eingeleitet Lake Street Buy
2016-11-21 Herabstufung Barrington Research Outperform → Mkt Perform
2016-10-06 Herabstufung Sidoti Buy → Neutral
2016-05-03 Bestätigt Barrington Research Outperform
2015-08-06 Bestätigt Barrington Research Outperform
2015-03-27 Eingeleitet Dougherty & Company Buy
2014-02-25 Eingeleitet Laidlaw Buy
2013-08-01 Hochstufung Feltl & Co. Buy → Strong Buy
2012-11-12 Bestätigt Barrington Research Outperform
Alle ansehen

Surmodics Inc Aktie (SRDX) Neueste Nachrichten

pulisher
Oct 10, 2025

Applying big data sentiment scoring on Surmodics Inc.2025 Price Targets & Verified Chart Pattern Trade Signals - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

How moving averages guide Surmodics Inc. trading2025 Price Action Summary & Weekly Consistent Profit Watchlists - newser.com

Oct 10, 2025
pulisher
Oct 09, 2025

What MACD signals say about Surmodics Inc.July 2025 Review & Weekly High Potential Alerts - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Has Surmodics Inc. formed a bullish divergence2025 Support & Resistance & Daily Oversold Bounce Ideas - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Surmodics (NASDAQ:SRDX) Receives "Sell (D-)" Rating from Weiss Ratings - MarketBeat

Oct 09, 2025
pulisher
Oct 06, 2025

Measuring Surmodics Inc.’s beta against major indicesBull Run & Reliable Volume Spike Trade Alerts - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Is Surmodics Inc. stock supported by strong cash flowsQuarterly Earnings Summary & Stepwise Trade Execution Plans - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Surmodics Inc Stock Analysis and ForecastGrowth vs. Value Investing & High Yield Trading Alerts - earlytimes.in

Oct 06, 2025
pulisher
Oct 06, 2025

Statistical indicators supporting Surmodics Inc.’s strengthWeekly Volume Report & Fast Gain Swing Alerts - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Does Surmodics Inc. fit your quant trading model2025 Trading Volume Trends & Accurate Trade Setup Notifications - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Risk vs reward if holding onto Surmodics Inc.July 2025 Levels & Verified Chart Pattern Signals - newser.com

Oct 06, 2025
pulisher
Oct 05, 2025

Multi factor analysis applied to Surmodics Inc.Quarterly Market Summary & High Accuracy Swing Entry Alerts - newser.com

Oct 05, 2025
pulisher
Oct 03, 2025

Surmodics, Inc. (NASDAQ:SRDX) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat

Oct 03, 2025
pulisher
Oct 03, 2025

Short interest data insights for Surmodics Inc.Entry Point & Short-Term Trading Opportunity Alerts - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Is Surmodics Inc. stock a buy for dividend growthAnalyst Upgrade & Free Real-Time Market Sentiment Alerts - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

How to monitor Surmodics Inc. with trend dashboards2025 Short Interest & Reliable Price Action Trade Plans - newser.com

Oct 03, 2025
pulisher
Oct 02, 2025

Published on: 2025-10-02 22:35:48 - newser.com

Oct 02, 2025
pulisher
Sep 30, 2025

Is Surmodics Inc. forming a reversal patternTrade Performance Summary & Verified Momentum Stock Alerts - newser.com

Sep 30, 2025
pulisher
Sep 29, 2025

US FTC delays GTCR-Surmodics evidentiary hearing until Feb. 2, 2026 - MLex

Sep 29, 2025
pulisher
Sep 28, 2025

What drives Surmodics Inc stock priceQuarterly Earnings Review & Low Risk Capital Growth Plans - earlytimes.in

Sep 28, 2025
pulisher
Sep 28, 2025

Is Surmodics Inc a good long term investmentTrend Following Strategies & Outstanding Return Stocks - earlytimes.in

Sep 28, 2025
pulisher
Sep 28, 2025

Published on: 2025-09-28 02:08:28 - newser.com

Sep 28, 2025

Finanzdaten der Surmodics Inc-Aktie (SRDX)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Surmodics Inc-Aktie (SRDX) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
DANTZKER DAVID
Director
Feb 13 '25
Option Exercise
27.30
5,275
144,008
44,399
BEDOYA JOSE H
Director
Feb 14 '25
Option Exercise
27.30
5,275
144,008
34,232
KNIGHT SUSAN E
Director
Jan 24 '25
Option Exercise
27.30
7,358
200,873
42,506
Arens Timothy J.
Chief Financial Officer
Nov 26 '24
Sale
39.44
7,009
276,453
70,350
$314.52
price down icon 1.83%
medical_devices STE
$235.83
price down icon 1.50%
$65.12
price down icon 4.35%
medical_devices PHG
$27.33
price down icon 2.50%
$71.01
price down icon 4.32%
medical_devices EW
$73.94
price down icon 1.66%
Kapitalisierung:     |  Volumen (24h):